Monday, October 26, 2026 · Daily editionET --:--:--

Looking for volunteers

Ventral or Inguinal Hernia, Robotically Repaired With OviTex Mesh

NCT04779918 · Tela Bio Inc · Updated 5 May 2026

What is being tested
OviTex Reinforced Tissue Matrix
For
Hernia, Ventral; Hernia, Inguinal
Kind of study
Tests a treatment or device on volunteers. No drug phase (a device or procedure study).
Who can join
Ages 21 years and older. About 160 people. The full rules are on the registry page.
Where
United States (10 sites)
When
Starts or started 29 April 2021, ends 30 Dec 2029. Registered 3 March 2021.
Results
None posted yet.

In the researchers' words

This study is designed to evaluate the post-operative complications and hernia recurrence following the use of OviTex in subjects with ventral or inguinal hernias. Up to 160 subjects will participate in the study from up to 20 investigator sites.
ClinicalTrials.gov, NCT04779918

Sites

  • University of South AlabamaMobile, Alabama, United States
  • SurgOneDenver, Colorado, United States
  • GenesisCareDestin, Florida, United States
  • Surgical Healing Arts CenterFort Myers, Florida, United States
  • St. Luke's HospitalOverland Park, Kansas, United States
  • University of LouisvilleLouisville, Kentucky, United States
  • Munson HealthcareTraverse City, Michigan, United States
  • St. Francis HospitalRoslyn, New York, United States
  • Mohawk Valley Health SystemUtica, New York, United States
  • Houston MethodistHouston, Texas, United States